Capas, Nito A.

HRN: 21-74-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2022
CO-AMOXICLAV 625MG (TAB)
08/06/2022
08/14/2022
PO
625mg
BID
Uncomplicated UTI
Waiting Final Action 
08/08/2022
CEFTRIAXONE 1G (VIAL)
08/08/2022
08/15/2022
IVTT
2g
Q24hrs
UTI
Waiting Final Action 
08/09/2022
CEFUROXIME 1.5GM (VIAL)
08/09/2022
08/16/2022
IV
1.5g
Q8h
Prophylaxis Prior To OR
Waiting Final Action 
08/09/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/09/2022
08/16/2022
IV
500mg
Q8h
Prophylaxis Prior To OR
Waiting Final Action 
08/10/2022
CLINDAMYCIN 300MG (CAP)
08/10/2022
08/17/2022
PO
300mg
QID
Post-op
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: